During the past decade, Pecsi Tudomanyegyetem conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 23 clinical trials were completed, i.e. on average, 79.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 15 clinical trials were completed. i.e. 214.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pecsi Tudomanyegyetem" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Takeda" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Ferring Pharmaceuticals" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pecsi Tudomanyegyetem" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Pecsi Tudomanyegyetem" are "Colitis, Ulcerative" (3 trials), "Prostate Cancer" (3 trials), "Atrial Fibrillation" (2 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Pecsi Tudomanyegyetem" in a lesser frequency.

Most popular intervention types in "Pecsi Tudomanyegyetem" are "Drug" (41 trials), "Biological" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (2 trials), "Degarelix" (2 trials), "Edoxaban" (2 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pecsi Tudomanyegyetem" are 40 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pecsi Tudomanyegyetem". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Pecsi Tudomanyegyetem, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pecsi Tudomanyegyetem, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".

Pecsi Tudomanyegyetem has several departments that took part in Clinical trials: "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet" - 19 trials, "University of Pecs, I st Dept of Internal Medicine" - 11 trials, "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" - 7 trials, "University of Pécs/Medical School/Heart Institute" - 4 trials, "Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases" - 3 trials, "Pecsi Tudomanyegyetem Neurologiai Klinika" - 3 trials, "2nd Department of Medicine and Nephrological Center" - 3 trials, "University of Pécs Department of Oncotherapy" - 2 trials, "PTE Department of ENT" - 2 trials, "Department of Neurology, University of Pécs" - 2 trials, "Medical Center of the University of Pecs, 1st Clinic for Internal Medicine" - 2 trials, "Pécsi Tudományegyetem Klinikai Központ: Immunológiai és Reumatológiai Klinika" - 2 trials, "Dept of Gastroenterology, Szent Gyorgy Hospital" - 2 trials, "Department of Anesthesiology and Intensive Therapy, Medical School, University of Pécs" - 2 trials, "University of Pecs, 1st internal Med. Dept., Pulmonology" - 2 trials